Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO

🇮🇹Italy

Country: 🇮🇹Italy

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Evaluation of the Effect of Liposomal L-Arg and Vit C Integration on Mitochondrial Function in Patients With Heart Failure

Phase 3

Recruiting

Conditions: Heart Failure

Interventions: Drug: L-arginine and liposomal vitamin C

First Posted Date: 2023-09-21

Last Posted Date: 2024-04-22

Lead Sponsor: Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico

Target Recruit Count: 56

Registration Number: NCT06044194

Locations: 🇮🇹
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milan, Lombardia, Italy

Efficacy and Safety of Bulevirtide (BLV) Therapy in HDV Chronic Hepatitis (CHD) in Italy

Completed

Conditions: Hepatitis D

Interventions: Drug: Bulevirtide

First Posted Date: 2023-07-27

Last Posted Date: 2023-07-27

Lead Sponsor: Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico

Target Recruit Count: 50

Registration Number: NCT05962307

Locations: 🇮🇹
Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Division of Gastroenterology and Hepatology, Milan, Italy., Milan, MI, Italy

Change in Inflammatory State in Patients Undergoing Transcatheter Ablation of Atrial Fibrillation

Recruiting

Conditions: Atrial Fibrillation
Marker of Inflammation
Arrhythmia
Inflammation

First Posted Date: 2023-07-27

Last Posted Date: 2023-09-13

Lead Sponsor: Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico

Target Recruit Count: 180

Registration Number: NCT05961865

Locations: 🇮🇹
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milan, Italy

Diet in Elderly With Type 2 Diabetes

Not Applicable

Not yet recruiting

Conditions: Diabetes Mellitus
Sarcopenic Obesity
Diabetes Complications
Sarcopenia
Diabetes Mellitus, Type 2

Interventions: Dietary Supplement: mediterranean diet with adequate protein intake

First Posted Date: 2023-07-27

Last Posted Date: 2023-07-27

Lead Sponsor: Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico

Target Recruit Count: 100

Registration Number: NCT05961878

Locations: 🇮🇹
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy

Molecular vs Conventional Microbiologic Diagnosis for Infections in Lung Transplantation

Recruiting

Conditions: Lung Transplant Infection
Molecular Diagnostic
Bacterial Infections
Tracheobronchitis
Pneumonia

Interventions: Diagnostic Test: BioFire Pneumonia Panel Plus

First Posted Date: 2023-07-25

Last Posted Date: 2023-07-25

Lead Sponsor: Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico

Target Recruit Count: 53

Registration Number: NCT05960383

Locations: 🇮🇹
Irccs Fondazione Ca' Granda Policlinico Di Milano, Milano, Italy

Prospective Evaluation of Diagnosis and Treatment of Patients With Autoimmune Cytopenias Including Autoimmune Hemolytic Anemia, Immune Thrombocytopenia, and Chronic Idiopathic/Autoimmune Neutropenia

Recruiting

Conditions: Cold Agglutinin Disease
Autoimmune Hemolytic Anemia
Chronic Idiopathic Neutropenia
Myelodysplastic Syndromes
Immune Thrombocytopenia
Autoimmune Neutropenia

Interventions: Biological: cytokine essays
Biological: NGS
Biological: Fecal microbiome
Drug: Thrombopoietin Receptor Agonist
Drug: G-CSF
Drug: Erythropoietin
Drug: Luspatercept

First Posted Date: 2023-07-05

Last Posted Date: 2024-10-11

Lead Sponsor: Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico

Target Recruit Count: 200

Registration Number: NCT05931718

Locations: 🇮🇹
Fondazione Irccs Ca' Granda Ospedale Maggiore Policlinico, Milano, Italy

VSL#3® vs Placebo in the Treatment of Fatigue and Other Symptoms in Long Covid (DELong#3)

Not Applicable

Recruiting

Conditions: Long COVID

Interventions: Dietary Supplement: Placebo
Dietary Supplement: VSL#3®

First Posted Date: 2023-05-24

Last Posted Date: 2023-05-24

Lead Sponsor: Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico

Target Recruit Count: 96

Registration Number: NCT05874089

Locations: 🇮🇹
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, MI, Italy

Boosting Psychotherapy Effects by Means of Transcranial Direct Current Stimulation

Not Applicable

Completed

Conditions: Major Depressive Disorder

Interventions: Device: tDCS

First Posted Date: 2023-05-19

Last Posted Date: 2023-05-19

Lead Sponsor: Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico

Target Recruit Count: 54

Registration Number: NCT05866042

Locations: 🇮🇹
Fondazione IRCCS Ca' Granda - Ospedale Maggiore Policlinico, Milan, MI, Italy

A Big Data Approach to Predict NEOnatal Acute Kidney Injury in Newborns expoSed to nephroTOxic Drugs (NeoAKI STOP)

Not yet recruiting

Conditions: Machine Learning
Premature Birth
Drug Interaction
Drug Toxicity
Drug-Induced Nephropathy
Acute Kidney Injury
Drug Use
Newborn Morbidity

First Posted Date: 2023-05-09

Last Posted Date: 2023-05-09

Lead Sponsor: Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico

Target Recruit Count: 4200

Registration Number: NCT05851222

Locations: 🇮🇹
Neonatal Intensive Care Unit, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milan, MI, Italy

Pembrolizumab Plus Lenvatinib in Previously Treated Classic Kaposi Sarcoma

Phase 2

Not yet recruiting

Conditions: Kaposi Sarcoma
Refractory Kaposi Sarcoma
Classic Kaposi Sarcoma

Interventions: Drug: Pembrolizumab + Lenvatinib

First Posted Date: 2023-05-06

Last Posted Date: 2023-12-18

Lead Sponsor: Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico

Target Recruit Count: 25

Registration Number: NCT05846724

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy